Sharemaestro Newsreel

MFG Wealth Management Inc. Takes Position in NeoGenomics, Inc. $NEO

MFG Wealth Management Inc. has initiated a position in NeoGenomics, Inc. (NASDAQ:NEO) by purchasing 83,462 shares valued at approximately $1.22 million, representing about 0.06% of the company. Institutional investors and hedge funds collectively own 98.5% of NeoGenomics, which has received a "Moderate Buy" consensus …

Thermo Fisher Scientific Inc. $TMO is Professional Advisory Services Inc.'s 5th Largest Position

Professional Advisory Services Inc. has increased its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 9.8%, making it their fifth-largest holding with 64,819 shares valued at $32.5 million. Institutional investors and hedge funds collectively own 89.23% of the company's stock, and analysts maintain a …

Natera, Inc. 2026: Revenue $752.75M, EPS ($0.47) — 10-Q Summary

Natera, Inc. (NTRA) reported its 2026 financial results, showing a significant revenue increase to $752.75 million for the quarter, up 37.7% year-over-year. The company posted a net loss of ($66.97 million) and a diluted loss per share of ($0.47), which represents an improvement compared …

Beacon Investment Advisory Services Inc. Sells 899 Shares of Mettler-Toledo International, Inc. $MTD

Beacon Investment Advisory Services Inc. has reduced its stake in Mettler-Toledo International, Inc. by 16.7%, selling 899 shares and now holding 4,479 shares valued at $5.72 million. Other institutional investors have adjusted their positions, with most increasing their holdings. Analyst sentiment for Mettler-Toledo is …

IDEXX Laboratories, Inc. (IDXX) stock price, news, quote and history

This article provides a comprehensive overview of IDEXX Laboratories, Inc. (IDXX) stock, including its current price, key financial statistics, historical performance, and analyst ratings. It details the company's operations in animal diagnostics, water quality, and veterinary software, and compares its performance to benchmarks like …

PensionDanmark Pensionsforsikringsaktieselskab Increases Stake in Agilent Technologies, Inc. $A

PensionDanmark Pensionsforsikringsaktieselskab increased its stake in Agilent Technologies, Inc. by 9.6% during the second quarter, adding 7,371 shares to its holdings, now valued at approximately $11.1 million. Analysts maintain a "Moderate Buy" rating with a consensus target price of $159.35. Agilent Technologies exceeded quarterly …

Empowered Funds LLC Increases Stock Holdings in Illumina, Inc. $ILMN

Empowered Funds LLC significantly increased its stake in Illumina, Inc. (NASDAQ:ILMN) by 104.2% in the first quarter, now holding 12,996 shares valued at approximately $1.6 million. This comes as institutional investors collectively own 89.42% of the company, and Illumina reported strong Q1 earnings, beating …

Dimensional Fund Advisors LP Sells 123,826 Shares of Guardant Health, Inc. $GH

Dimensional Fund Advisors LP reduced its stake in Guardant Health, Inc. by 40.4% in the first quarter, selling 123,826 shares. Despite this and significant insider selling, Guardant Health's stock price rose 6.9% to $168.48, near its 12-month high, reflecting a "Moderate Buy" consensus from …

Aurora Investment Managers LLC. Makes New Investment in IDEXX Laboratories, Inc. $IDXX

Aurora Investment Managers LLC. has acquired a new stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX), purchasing 4,638 shares valued at approximately $2.44 million. This investment makes IDEXX Laboratories the 21st largest position in Aurora Investment Managers' portfolio, representing 1.5% of its total investments. The article …

Community Trust & Investment Co. Increases Position in IQVIA Holdings Inc. $IQV

Community Trust & Investment Co. has increased its stake in IQVIA Holdings Inc. (NYSE:IQV) by 5% in the second quarter, bringing its total holdings to 92,668 shares valued at $17.9 million. This comes as IQVIA exceeded quarterly earnings expectations with adjusted EPS of $3.15 …

RadNet Inc (RDNT) Stock News Today

This article from TradingKey provides a brief update on RadNet Inc (RDNT) stock. It notes the current stock price, market capitalization, and a positive daily performance. The page indicates that more news, earnings, and analyst ratings for RadNet Inc will be coming soon.

Myriad Genetics (NASDAQ:MYGN) Lowered to "Sell" Rating by Wall Street Zen

Wall Street Zen has downgraded Myriad Genetics (NASDAQ:MYGN) to a "Sell" rating from "Hold," citing the company's recent earnings miss and declining revenue. The stock opened significantly below its moving averages, and the analyst consensus for Myriad Genetics is now "Reduce" with an average …

Qiagen N.V. (NYSE: QGEN) Q2 2026 profit, $496.7M synthetic buyback and cash flows

QIAGEN N.V. (NYSE: QGEN) reported Q2 2026 net sales of $535.04 million and net income of $103.401 million, with diluted EPS of $0.50. The company executed a $496.7 million synthetic share repurchase in January 2026, reducing outstanding shares by 5.0%, and approved a $0.35 …

UN, Danaher, NHS & J&J: This Week's Top Healthcare Stories

This article covers major healthcare news, including the UN's warning about stalling Sustainable Development Goals due to declining funding, significant executive leadership changes at Danaher and Johnson & Johnson, and P&G's strategic acquisition of Thorne to expand its wellness portfolio. Additionally, it highlights a …

Key facts: Natera, Inc. Q2 revenue $752.8M; JP Morgan raises PT to $360

Natera (NTRA) reported strong Q2 results with revenue of $752.8M, a 37.7% year-over-year increase, and a record 1.04M tests processed. Following these results, JP Morgan raised its price target for Natera from $315.00 to $360.00 per share, reflecting a revised outlook for the stock. …

Guardant Health, Inc. (NASDAQ:GH) Given Average Rating of "Moderate Buy" by Analysts

Analysts have assigned Guardant Health, Inc. (NASDAQ:GH) an average rating of "Moderate Buy," with a consensus 12-month price target of $183.78 among 25 analysts. Several firms recently raised their price targets, indicating continued bullish sentiment. Despite insider selling, institutional investors hold a significant stake …

Assenagon Asset Management S.A. Purchases 109,284 Shares of IQVIA Holdings Inc. $IQV

Assenagon Asset Management S.A. significantly increased its stake in IQVIA Holdings Inc. by 47.3% in the second quarter, acquiring an additional 109,284 shares. This move is part of a broader trend of institutional investors modifying their holdings in IQVIA, which includes other major purchases …

NeoGenomics Appoints Carolyn Starrett to its Board of Directors

NeoGenomics, Inc. has appointed Carolyn Starrett to its Board of Directors. Ms. Starrett brings over 25 years of experience in commercial, product, and operations roles at data and technology companies, with significant expertise in AI and data insights in cancer care. Her appointment is …

Personalis, Inc. (NASDAQ:PSNL) Receives Average Rating of "Hold" from Analysts

Personalis, Inc. (NASDAQ:PSNL) has received an average "Hold" rating from nine analysts, with a 12-month average price target of $14.25. Recent insider selling by executives, totaling over $5.6 million in shares, has been noted. The company's latest quarterly earnings showed mixed results, with revenue …

Natera, Inc. Stock 12‑Month Price Target Raised to $317.33, Implies 20% Upside

Analysts have raised the average 12-month price target for Natera, Inc. (NTRA) stock to $317.33, up from $283.81, with a potential upside of approximately 20% based on its August 6 closing price. This new target is based on estimates from 21 analysts, with forecasts …

Thermo Fisher CEO Marc Casper sells $8.6m in common stock

Marc N. Casper, CEO of Thermo Fisher Scientific (NASDAQ:TMO), sold 15,000 shares of company stock worth approximately $8.6 million on August 5, 2026, following the exercise of options. These transactions were conducted under a Rule 10b5-1 trading plan. The sales occurred shortly after Thermo …

Waters (WAT) After Fresh Guidance And Earnings Update Is The Valuation Case Still Intact

Wall Street Zen Downgrades Fulgent Genetics (NASDAQ:FLGT) to Strong Sell

Wall Street Zen has downgraded Fulgent Genetics (NASDAQ:FLGT) from a "sell" to a "strong sell" rating, despite a broader analyst consensus of "hold" with a $27.50 price target. This downgrade follows Fulgent's recent quarterly earnings report, which missed analyst expectations for both EPS and …

Waters Corp (NYSE: WAT) director sells 3,626 shares after option exercise

Waters Corp director Christopher A. Kuebler exercised stock options for 3,626 shares at $136.43 per share on August 6, 2026. On the same day, he sold all 3,626 common shares at $397.94 per share in an open market transaction. This transaction resulted in approximately …

Quest Diagnostics Incorporated (QDI.F) Stock Price, News, Quote & History

Piper Sandler Maintains Sotera Health Company(SHC.US) With Buy Rating, Raises Target Price to $25

Piper Sandler has reiterated its "Buy" rating for Sotera Health Company (SHC.US) and increased the target price to $25. This indicates a positive outlook from the analyst firm regarding the company's future performance.

Precipio Inc (PRPO) Stock News Today

This article provides current stock news for Precipio Inc (PRPO). As of the article's publication, PRPO's stock is trading at $23.970, up +2.17%, with a market cap of 42.75M USD. The article notes that more news is expected soon regarding the company.

Biodesix Inc (BDSX) Stock News Today

Guardant Health (GH) Q2 2026 Earnings Call Transcript

Guardant Health (GH) reported strong Q2 2026 earnings with a 44% year-over-year revenue growth, driven by its Oncology, Biopharma & Data, and Screening segments. Key milestones included FDA approval for Guardant360 Liquid CDx and a higher-throughput Shield workflow, along with Shield's inclusion in American …

IQVIA Holdings Inc (IQV) Stock News Today

This article provides recent news updates for IQVIA Holdings Inc (IQV) stock, including its latest closing price, market capitalization, and P/E ratio. It highlights two recent news items: a report on Amgen Inc (AMGN) stock movement from July 28, and IQVIA Holdings Inc's own …

Price to sales forward of Fulgent Genetics, Inc. – MUN:7F0

This page from TradingView provides financial information for Fulgent Genetics, Inc. (MUN:7F0), specifically focusing on its forward price-to-sales ratio. The content appears to be a stub or a placeholder, as no specific values or detailed data regarding the price-to-sales metric are visible.

Biodesix (BDSX) Stock Pullback Puts Focus On Losses Despite Stronger Margins

Biodesix (BDSX) stock saw a nearly 3% pullback despite reporting a narrowed net loss of US$7.3m and a strong gross margin of 82% in Q2 2026. While revenue increased by 34% year-over-year, the market focused on the company's continued losses, raising questions about whether …

RadNet (RDNT) To Report Earnings Tomorrow: Here Is What To Expect

RadNet (RDNT) is set to report its earnings tomorrow after market close. Analysts expect the diagnostic imaging company's revenue to grow 22.1% year-on-year, an improvement from the previous year. Despite a recent miss on EPS estimates, the company has a history of exceeding Wall …

Balefire LLC Sells 12,141 Shares of IQVIA Holdings Inc. $IQV

Balefire LLC significantly reduced its stake in IQVIA Holdings Inc. by selling 12,141 shares, retaining 4,326 shares valued at $836,000. Despite this, institutional investors collectively own 89.62% of IQVIA, and the company reported strong quarterly earnings, exceeding analyst estimates, and authorized a $2 billion …

Natera, Inc. (NTRA) chair logs 2,000-share sale via 10b5-1 plan

Natera, Inc.'s executive chairman, Matthew Rabinowitz, sold 2,000 shares of common stock on August 7, 2026, at $320.90 per share. This transaction was conducted under a pre-adopted Rule 10b5-1 trading plan from December 5, 2025. Following the sale, Rabinowitz directly holds 2,275,394 shares and …

Natera, Inc. (NTRA) co-founder Jonathan Sheena sells 9,150 shares

Natera, Inc. co-founder and director Jonathan Sheena sold a total of 9,150 shares of common stock on August 7, 2026, through open-market transactions. These sales were executed under a Rule 10b5-1 trading plan adopted in December 2025, with prices ranging from $308.4000 to $320.9000 …